Parkinson’s Disease Plasma
About: Parkinson's Disease Plasma - Cryopreserved human plasma collected from clinically confirmed Parkinson's Disease donors. Parkinson's Disease plasma is ideal for neurodegeneration and systemic inflammation studies.
| Lot Number | Condition | Volume | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 73645 | Parkinson's Disease | 1.0 ML | Native American | 77 | Female |
Irmantidine 137mg BID vytery TID Lisinoprol 5mg QD Gabapentin 300mg TID vitiman D3 Rytery
|
18 | $495.00 | ||
| 73016 | Parkinson's Disease | 1.0 ML | Caucasian | 75 | Male |
Repatha® (evolocumab) /140mg/every 2 weeks Finasteride /5mg/QD Alfuzosin/10mg/QD Pantoprazole/40mg/PRN Baclofen 5 mg QD- No longer taking
|
13 | $495.00 | ||
| 72958 | Parkinson's Disease | 1.0 ML | Caucasian | 55 | Female |
Carvidopa Levedopa/ 100mg/25mg 4x QID Gabapentin Lexapro 20mg QD Neurontin /300mg/QN
|
18 | $495.00 | ||
| 73116 | Parkinson's Disease | 1.0 ML | Caucasian | 59 | Male |
Xadago 100 mg QD Rytary
|
13 | $495.00 | ||
| 72905 | Parkinson's Disease | 1.0 ML | Caucasian | 68 | Male |
Zoloft 100 mg QD Tricor 120 mg QD Amantadine 100 mg BID Valsartan 80 mg QD Sinemet 200 mg BID
|
14 | $495.00 | ||
| 73019 | Parkinson's Disease | 1.0 ML | Caucasian | 70 | Female |
Carbidopa/Levodopa 25/100 IR 10 tabs po QD Carbidopa/Levodopa 25/100 ER 2 tabs po QHS Selegiline 5 mg po QD Paroxetine HCL 30 mg po QD Levothyroxine 0.75 mcg po QD Fluocinolone Acetonide Cream QD Fluocinonide Topical solution PRN Restasis BID Clobetasol Propionate Cream Weekly Vitamin D3 2000 IU po QD Multivitamin po QD Melatonin 10 mg Tylenol PRN
|
19 | $495.00 | ||
| 72955 | Parkinson's Disease | 1.0 ML | Caucasian | 78 | Male |
Extended release Carbidopa / Levodopa/2500mg/QID Tamsulosin/0.4mg/QD SAW PALMETTO/450mg/QD VIt D QW Vit C
|
13 | $495.00 | ||
| 78433 | Parkinson's Disease | 1.0 ML | Male |
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
|
1 | $495.00 | ||||
| 78434 | Parkinson's Disease | 1.0 ML | Male |
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
|
1 | $495.00 | ||||
| 78435 | Parkinson's Disease | 1.0 ML | Male |
Acetylsalicylic acid, Bisoprolol, Carbidopa/levodopa
|
1 | $495.00 |
Parkinson’s Disease Plasma | High-Quality Human Plasma from Parkinson’s Disease Donors
Parkinson’s Disease Plasma is collected from donors clinically diagnosed with Parkinson’s Disease and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in Parkinson’s Disease pathophysiology.
Product Features
- Research Use Only (RUO)
- Plasma collected from clinically confirmed Parkinson’s Disease donors
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
De-identified Donor Data
- Verified Parkinson’s Disease diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional Parkinson’s Disease-specific metadata available
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Parkinson’s Disease plasma is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.
Protocols & Documentation
-
Download
Plasma Isolation
Protocol for plasma separation from anticoagulated whole blood, including processing, storage, and traceability requirements.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
Parkinson's Disease Publications
Plasma
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom Plasma cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.